Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Jupiter Life Line Hospitals Earnings Call: Key Takeaways

Jupiter reports strong FY26 performance with 15.2% revenue growth to ₹1,499.8cr. Focus remains on greenfield expansion in Western India with asset-heavy ownership model.

Why this was an Alfa AlertNot a filter event. Results were positive and Dombivli opened ahead of schedule, but no material guidance beat was quantified.
Highlights
Revenue growthFY26 consolidated revenue up 15.2% YoY.
MarginsFY26 EBITDA margin at 22.9%; Q4 margin at 23%.
Demand visibilityStrong local demand; 61.2% bed occupancy in pre-existing hospitals.
Management confidenceHigh; citing early ahead-of-schedule commissioning of Dombivli facility.

Growth

FY26 Revenue up 15.2% to ₹1,499.8cr; PAT grew to ₹194.2cr. ARPOB increased 11.7% to ₹67,700.

Outlook

Adding 1,700 beds; targeting 3,000 total capacity. Dombivli ahead of schedule; Pune South on track for 2028.

Risks

Currency depreciation affecting capex costs; inflationary pressures on consumables; execution risks in new multi-city greenfield projects.

Source

Earnings Call filed with BSE, NSE: JLHL. Summary written with AI assistance from the document.

Read the document ↗

Jupiter Life Line Hospitals Ltd: key numbers

Share price
₹265.65
Market cap
₹8,709 Cr
Revenue (annual)
₹1,500 Cr
Net profit (annual)
₹194.0 Cr
P/E (TTM)
46.4×Sector 57.8×
Promoter holding
40.91%+0.00% QoQ
FII holding
9.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Jupiter Life Line Hospitals Ltd

All →